Search

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

A partnership between WhiteLab Genomics and Debiopharm will seek to use AI to streamline the development of targeted cancer therapies.

How a collaboration between different organizations aims to advance perfusion for cell and gene therapies.

The rocket-fueled dreams of a young engineer applied to the cleanroom industry.

Could paper-based secondary packaging help companies be more sustainable?

Lentiviruses are growing in the advanced therapy landscape. Experts at Sartorius discuss the unique challenges that come with their production

Claus Zieler reflects on his time at Astellas and his role at EFPIA.

The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact

Claus Zieler from Astellas and EFPIA addresses the challenges facing innovation in Europe, including regulatory burdens and access to medicines.